Background and Purpose Although epidemiologic investigations are tryin
g to clarify the role of plasma lipid concentrations (primarily choles
terol and its subfractions) as risk factors for both ischemic and hemo
rrhagic stroke, little information is available regarding the effect o
f sustained hypercholesterolemia on cerebral perfusion. Methods Region
al cerebral blood flow (CBF) was measured by the Xe-133 inhalation met
hod in 25 heterozygous patients (four untreated) affected with familia
l hypercholesterolemia. In 15 patients regional CBF was repeated 20 mi
nutes after intravenous administration of acetazolamide (10 mg/kg body
wt) to evaluate cerebrovascular reactivity. Correlations among cerebr
al perfusion data, present or pretreatment plasma lipid concentrations
, and certain other clinical features were assessed by ANOVA. Results
Both basal regional CBF and cerebrovascular reactivity were normal in
the vast majority of patients compared with age- and sex-matched norma
l control subjects. CBF was significantly dependent on pretreatment lo
w-density lipoprotein cholesterol (LDL-C) concentration (P=.005) and t
he presence of symptomatic ischemic heart disease (P=.015). CBF was on
ly slightly dependent on age (P=.05) and was not dependent on either l
ipoprotein(a) or present LDL-C concentration. CBF did not differ betwe
en treated and untreated patients, and the perfusional increase induce
d by acetazolamide was not related to any other variable. Conclusions
Cerebral perfusion and cerebrovascular reactivity were maintained with
in the normal range despite longlasting, severe hypercholesterolemia,
even if a somewhat lower CBF was found in those patients with the high
est LDL-C pretreatment levels. These results are in accord with the ep
idemiologic data that implicate hypercholesterolemia as a minor risk f
actor, if a risk factor at all, for intracranial atherosclerosis and i
schemic stroke.